Search Results - "Gérolami, R"

Refine Results
  1. 1
  2. 2
  3. 3

    Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection by Colson, P., Dhiver, C., Gérolami, R.

    Published in Clinical microbiology and infection (01-12-2008)
    “…The recent description of chronic hepatitis E in organ transplant recipients deserves increased awareness in the context of hepatitis E virus (HEV) infection…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement by Borentain, P, Soussan, J, Resseguier, N, Botta-Fridlund, D, Dufour, J.-C, Gérolami, R, Vidal, V

    Published in Diagnostic and interventional imaging (01-06-2016)
    “…Abstract Purpose The goal of this study was to identify clinical and imaging variables that are associated with an unfavorable outcome during the 30 days…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Liver transplantation in a patient treated by sorafenib for hepatocellular carcinoma by Borentain, P, Gregoire, E, Hardwigsen, J, Garcia, S, Durieux, O, Le Treut, Y.-P, Gérolami, R

    “…Summary Sorafenib is a multikinase inhibitor currently used in the palliative treatment of advanced hepatocellular carcinoma. In patients with small…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E by Perrin, H Blasco, Cintas, P, Abravanel, F, Gérolami, R, d'Alteroche, L, Raynal, J-N, Alric, L, Dupuis, E, Prudhomme, L, Vaucher, E, Couzigou, P, Liversain, J-M, Bureau, C, Vinel, J-P, Kamar, N, Izopet, J, Peron, J-M

    Published in Emerging infectious diseases (01-11-2015)
    “…Neurologic disorders, mainly Guillain-Barré syndrome and Parsonage–Turner syndrome (PTS), have been described in patients with hepatitis E virus (HEV)…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Letter: nutritional benefits of rifaximin in cirrhotic patients by Borentain, P., Rouabah, K., Allard, G., Ressiot, E., Gerolami, R.

    “…Linked content This article is linked to Kang et al paper. To view this article visit https://doi.org/10.1111/apt.14275…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Letter: liver transplantation for acute HEV infection in cirrhotic patients in France by Borentain, P., Colson, P., Gregoire, E., Allard, G., Gerolami, R.

    Published in Alimentary pharmacology & therapeutics (01-08-2017)
    “…Linked ContentThis article is linked to Borentain and Colson et al paper. To view this article visit https://doi.org/10.1111/apt.14188…”
    Get full text
    Journal Article
  18. 18

    Enhanced in vivo adenovirus-mediated gene transfer to rat hepatocarcinomas by selective administration into the hepatic artery by GEROLAMI, R, CARDOSO, J, BRALET, M.-P, CUENOD, C.-A, CLEMENT, O, TRAN, P.-L, BRECHOT, C

    Published in Gene therapy (01-07-1998)
    “…Adenovirus-mediated gene therapy of experimental hepatocarcinoma is hindered by low transduction efficacy in vivo. We evaluated the extent of gene expression…”
    Get full text
    Journal Article
  19. 19
  20. 20

    A national survey of acute hepatitis E in France by RENOU, C., MOREAU, X., PARIENTE, A., CADRANEL, J.‐F., MARINGE, E., MORIN, T., CAUSSE, X., PAYEN, J.‐L., IZOPET, J., NICAND, E., BOURLIÈRE, M., PENARANDA, G., HARDWIGSEN, J., GEROLAMI, R., PÉRON, J.‐M., PAVIO, N.

    Published in Alimentary pharmacology & therapeutics (01-06-2008)
    “…Summary Background  Few data are available on the incidence, risk factors and contamination pathways involved in acute indigenous hepatitis E in developed…”
    Get full text
    Journal Article